Aortic valve patients share real-world safety and outcomes
Part of Heart & circulation clinical trials.
This observational registry collects information about people who need an aortic valve replacement using a biologic (bioprosthesis) valve. It aims to better understand safety and effectiveness in everyday care, not to test a new drug or procedure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult (18 years or older).
- Your doctor says you need to replace your aortic valve with a bioprosthesis (biologic valve).
- You can understand the study and agree to be included by signing consent.
- Your situation does not require emergency “salvage” surgery (urgent life-saving resuscitation before anesthesia).
- You are not excluded for not being able to provide consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows adults who are having aortic valve replacement to better understand outcomes across different hospitals in Europe. It may help your care team compare results and improve future treatment planning.
This study tracks patients getting a new heart valve (transcatheter aortic valve implantation) for severe aortic stenosis. It aims to understand long-term outcomes and safety in a real-world registry.
This study is tracking how well the Myval valve works in people with severe aortic stenosis who get it through a minimally invasive procedure called TAVI. It helps doctors learn more about the valve's safety and performance in real-world use.
This trial tests a new polymer heart valve for people with severe aortic valve narrowing or leakage. It aims to see if the valve is safe and works well as a replacement.
This trial tests a new type of aortic heart valve (PoliaValve) for people with severe aortic valve disease who need valve replacement surgery. If you qualify, you will receive the experimental valve and be followed for one year to see how well it works.
This registry is for people with severe, symptomatic aortic valve narrowing who are planning a TAVI procedure (a less invasive valve replacement). It aims to better track and improve how patients do after the valve is replaced, based on how the procedure is planned and performed.
Hear when a new Aortic Valve Stenosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.